Review: Long-acting insulin analogues do not improve glycaemic control but reduce nocturnal hypoglycaemia

Evidence-Based Medicine

Volumn 13, Issue 3, 2008, Pages 79-

  Smith, Steven A ^a   Hassan Murad, M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN; LONG ACTING DRUG; ORAL ANTIDIABETIC AGENT;

CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEATH; DRUG EFFICACY; GLYCEMIC CONTROL; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INFORMATION RETRIEVAL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MORBIDITY; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT SATISFACTION; QUALITY OF LIFE; SHORT SURVEY; VASCULAR DISEASE; VISUAL IMPAIRMENT;

EID: 45249084322     PISSN: 13565524     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebm.13.3.79     Document Type: Short Survey

References (2)

1. Clement S, Braithwaite SS, Magee MF, et al. Diabetes Care 2004;27:553-591.
2. Montori VM, Gandhi GY, Guyatt GH. Lancet 2007; 370:1104-6.